Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amphetamine-induced Sensitization PET Study
NCT03223844Unknown
- Sponsor
- Medical University of Vienna
- Start
- Jan 2018
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dextroamphetamine in schizophrenia and psychosis, sponsored by Medical University of Vienna. Primary endpoint: [18F]FDOPA Ki values at 4 weeks. Status: unknown.
02
Drugs
dextroamphetamine
03
Conditions
schizophreniapsychosis
Beyond the preview
Go deeper on NCT03223844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03223844.